Improving Methods to Collect and Analyze Overall Survival Data
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
The American Association for Cancer Research (AACR) released its annual Cancer Progress Report today. The report serves as an important record of the...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...